Lipoprotein(a), Cardiovascular Disease, and Calcific Aortic Valve Stenosis
Friday, May 8, 2020
1:30 PM – 2:10 PM
Participants should be aware of the following financial/non-financial relationships: Calvin Yeang, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Learning Objectives:
Discuss the evidence linking lipoprotein(a) to cardiovascular disease and aortic valve stenosis.
Explain the effect of lipid lowering therapies on lipoprotein(a) levels.
Develop concepts of how to clinically manage cardiovascular risk associated with elevated lipoprotein(a).
